Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
about
A proteomics approach to identifying key protein targets involved in VEGF inhibitor mediated attenuation of bleomycin-induced pulmonary fibrosisThe role of pleiotrophin and beta-catenin in fetal lung development.Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferationActivation of canonical Wnt signalling is required for TGF-β-mediated fibrosis.Blocking the Wnt/β-Catenin Pathway by Lentivirus-Mediated Short Hairpin RNA Targeting β-Catenin Gene Suppresses Silica-Induced Lung Fibrosis in Mice.The Wnt/β-catenin signaling pathway regulates the development of airway remodeling in patients with asthma.Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity.Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.Beneficial role of vitamin D3 in the prevention of certain respiratory diseases.Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) promotes lung fibroblast proliferation, survival and differentiation to myofibroblasts.Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung functionActivation of the WNT/β-catenin pathway attenuates experimental emphysema.Basic fibroblast growth factor activates β-catenin/RhoA signaling in pulmonary fibroblasts with chronic obstructive pulmonary disease in rats.Decoy Wnt receptor (sLRP6E1E2)-expressing adenovirus induces anti-fibrotic effect via inhibition of Wnt and TGF-β signaling.Wenyang Huazhuo Tongluo formula inhibits fibrosis via suppressing Wnt/β-catenin signaling pathway in a Bleomycin-induced systemic sclerosis mouse model.
P2860
Q28383207-E93AC516-A9B2-4032-BA6E-D4D7FB79B6ABQ33981440-4B8AF52D-F224-43DD-8C33-2C501C50312AQ35684848-C83C578C-1C96-4E6F-A4B4-D6F9D64BDD3EQ35863725-158022A5-C511-4A47-A464-4B459B5286C3Q36102377-2754760F-3923-4340-9DA8-0668BD1C1099Q36392172-E77B0B3D-80F3-41EB-8A64-BB1D75E42640Q36710937-A2447171-CFE6-4716-BEAE-F167D5CBB5F9Q37866602-E51EB9DC-9492-4553-85BD-31A6FE5A3F5DQ38135328-FE4EFF5B-6A16-4BC8-9824-7903AAB5398BQ38140574-825EEC14-B595-45A5-9E2B-E3C8CDE07112Q38524716-7E9812BB-BF17-4E8E-A8C4-FC7E2B097D80Q38908334-7D5E7BB4-5674-4E12-8520-E069E0220FF6Q39831271-D278F67D-B359-4566-BE47-227C6A0D0510Q42500477-73DE2CAE-C827-4AE5-BBF2-11F705CF3DF3Q47117290-708639CE-A8CA-4607-BB42-07D9D2A76A86Q54093499-DBCCF8F2-111B-45B7-9B12-991009B1A52E
P2860
Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
@en
type
label
Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
@en
prefLabel
Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
@en
P2093
P2860
P1476
Wnt pathway in pulmonary fibrosis in the bleomycin mouse model.
@en
P2093
Benjamin Carron
Herman T Yee
Mustapha Hajjou
Ting-An Yie
William Rom
P2860
P304
P356
10.1615/JENVIRONPATHOLTOXICOLONCOL.V28.I2.20
P577
2009-01-01T00:00:00Z